Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06032195
PHASE2

Study of Organ Perfusion in Heart Transplantation in Children

Sponsor: Dr. F. Köhler Chemie GmbH

View on ClinicalTrials.gov

Summary

The goal of this prospective randomized single blind multicenter phase II study is to compare organ perfusion with Custodiol-N and Custodiol in heart transplantation in children of all ages (birth to \<18 years) being listed on the waiting list for heart transplantation. The main question it aims to answer is: to compare the safety of Custodiol-N in heart transplantation in children in comparison to its precursor product Custodiol. Participants will receive either a heart to be transplanted, either perfused with Custodiol-N or Custodiol to Researchers will compare the two solutions to see if the new solution Custodiol-N is safe in heart transplantation in children.

Official title: A Prospective Randomized Single Blind Multicenter Phase II Study of Organ Perfusion With Custodiol-N Compared With Custodiol in Heart Transplantation in Children

Key Details

Gender

All

Age Range

24 Hours - 17 Years

Study Type

INTERVENTIONAL

Enrollment

15

Start Date

2023-08-15

Completion Date

2027-09

Last Updated

2026-01-30

Healthy Volunteers

No

Interventions

DRUG

Custodiol-N

heart will preserved in and will be treated with Custodiol-N solution

DRUG

Custodiol

heart will preserved in and will be treated with Custodiol solution

Locations (3)

Deutsches Herzzentrum der Charité

Berlin, Germany

Universitätsklinikum Gießen (UKGM), Kinderherzzentrum, Klinikum für Kinderherzchirurgie

Giessen, Germany

Klinikum der Universität München (LMU), Klinik und Poliklinik für Herzchirurgie, Chirurgische Klinik

München, Germany